Patient-reported outcomes for children on innovative cancer medicines
Part of Brain & nervous system, Cancer clinical trials.
This study asks children with cancer who are taking new, non-standard medicines to report their symptoms and quality of life. It aims to understand how these treatments affect daily life, even when standard treatments have stopped working.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 2 and 18 years old
- You are already taking part in the main SACHA study and have not yet started your new cancer treatment
- You or your parents can read and understand French, English, or Spanish well enough to answer questions
- You are receiving an innovative (new or non-standard) cancer medicine, for example because standard treatments did not work or are not available
- You are not eligible for or choose not to join an early-phase clinical trial in France
- You are being treated at a French pediatric cancer center that can prescribe chemotherapy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps children, teens, and young adults get an innovative cancer medicine when their disease has returned or hasn’t responded—and standard options are not available. It checks whether a “compassionate use” or off-label medicine plan can be carried out safely for the people who need it.
This trial helps children, teens, and young adults with cancer get early access to promising new drugs that are not yet fully approved for their age group. It collects information on how these drugs work in real-world use.
This study aims to understand how symptoms change over time in children with advanced cancerhare by having you and your child fill out surveys. Your participation can help improve care for other families facing similar challenges.
This study tests whether checking in with children about their symptoms three times a week helps manage side effects better. It could help improve comfort and care during cancer treatment.
This trial uses lab-grown tumor samples from your child to test which chemotherapy drugs work best for their specific cancer. The goal is to find the most effective treatment by testing medicines on their tumor cells before giving them to your child.
This study looks at how cancer treatment may affect children’s thinking and brain health. It may help doctors better understand risks so they can monitor and support learning and memory during and after treatment.
Hear when a new CNS Tumor, Childhood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.